AYURVEDIC MANAGEMENT OF GOUTY ARTHRITIS - A CLINICAL STUDY
Not Applicable
Completed
- Conditions
- Health Condition 1: M109- Gout, unspecified
- Registration Number
- CTRI/2021/04/032503
- Lead Sponsor
- Dr SHILPA SHREE C
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
SUBJECTS FULFILLING CRITERIAS OF AMERICAN COLLEGE OF RHEUMATOLOGY 1977 AND SUBJECTS WITH INCREASED LEVEL OF SERUM URIC ACID OF 7mg/dl to 10mg/dl IN MALE AND 6mg/dl to 10mg/dl IN FEMALE
Exclusion Criteria
1. SUBJECTS DIAGNOSED WITH OTHER INFLAMMATORY AND DEGENERATIVE JOINT DISEASE
2. SUBJECTS WITH HISTORY OF TRAUMA, FRACTURE JOINT, SURGICAL OR DIAGNOSTIC INTERVENTION WITH REFERENCE TO THE AFFECTED JOINT(S) IN PAST 1 YEAR.
3. PREGNANT AND LACTATING WOMEN
4. SUBJECTS WITH ANY UNCONTROLLED SYSTEMIC ILLNESS INCLUDING DIABETES MELLITUS, HYPERTENSION.
5. SUBJECTS WITH VATARAKTA WITH SPECIAL REFERENCE TO GOUTY ARTHRITIS PRESENTING WITH COMPLICATION INCLUDING JOINT DEFORMITIES.
6. ANY OTHER CONDITION INTERFERING THE COURSE OF TREATMENT.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method REDUCTION IN THE LEVELS OF SERUM URIC ACIDTimepoint: 30TH DAY, 45TH DAY
- Secondary Outcome Measures
Name Time Method REDUCTION IN THE CLASSICAL SIGNS AND SYMPTOMS OF VATARAKTATimepoint: REDUCTION IN THE SIGNS AND SYMPTOMS OF VATARAKTA ON 15th day, 30th DAY and 45th day